Danaher Co. (NYSE:DHR) Shares Acquired by Tenere Capital LLC

Tenere Capital LLC boosted its holdings in Danaher Co. (NYSE:DHR - Free Report) by 59.5% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 57,928 shares of the conglomerate's stock after purchasing an additional 21,600 shares during the quarter. Danaher comprises 3.5% of Tenere Capital LLC's portfolio, making the stock its 16th largest position. Tenere Capital LLC's holdings in Danaher were worth $13,297,000 as of its most recent SEC filing.

A number of other hedge funds have also recently made changes to their positions in the stock. Gilbert & Cook Inc. grew its position in shares of Danaher by 2.5% in the fourth quarter. Gilbert & Cook Inc. now owns 1,749 shares of the conglomerate's stock valued at $401,000 after purchasing an additional 42 shares during the period. Grimes & Company Inc. boosted its holdings in Danaher by 0.6% in the 4th quarter. Grimes & Company Inc. now owns 7,390 shares of the conglomerate's stock worth $1,696,000 after buying an additional 43 shares during the last quarter. Dakota Community Bank & Trust NA increased its stake in Danaher by 16.4% during the 4th quarter. Dakota Community Bank & Trust NA now owns 320 shares of the conglomerate's stock worth $73,000 after buying an additional 45 shares in the last quarter. Howard Capital Management Group LLC lifted its position in shares of Danaher by 4.1% in the third quarter. Howard Capital Management Group LLC now owns 1,229 shares of the conglomerate's stock valued at $342,000 after acquiring an additional 48 shares in the last quarter. Finally, Spinnaker Trust boosted its stake in shares of Danaher by 1.2% in the fourth quarter. Spinnaker Trust now owns 4,304 shares of the conglomerate's stock worth $988,000 after acquiring an additional 50 shares during the last quarter. 79.05% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of research analysts have weighed in on the company. Barclays raised their price objective on Danaher from $205.00 to $215.00 and gave the company an "overweight" rating in a report on Tuesday, April 22nd. Citigroup restated a "buy" rating on shares of Danaher in a report on Monday, April 7th. Jefferies Financial Group cut their price target on Danaher from $260.00 to $230.00 and set a "buy" rating for the company in a report on Tuesday, April 22nd. The Goldman Sachs Group dropped their target price on Danaher from $260.00 to $240.00 and set a "neutral" rating for the company in a report on Wednesday, April 23rd. Finally, Raymond James reissued a "market perform" rating on shares of Danaher in a research report on Monday, February 3rd. Five investment analysts have rated the stock with a hold rating and sixteen have given a buy rating to the company. According to MarketBeat, Danaher presently has an average rating of "Moderate Buy" and an average target price of $264.40.

Insider Activity at Danaher

In related news, SVP Brian W. Ellis sold 5,700 shares of the firm's stock in a transaction that occurred on Thursday, January 30th. The stock was sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the transaction, the senior vice president now owns 20,230 shares in the company, valued at $4,534,149.90. This trade represents a 21.98 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Insiders own 11.10% of the company's stock.

Danaher Stock Down 1.3 %

NYSE:DHR traded down $2.62 during mid-day trading on Monday, hitting $194.52. The stock had a trading volume of 1,046,140 shares, compared to its average volume of 3,346,016. Danaher Co. has a twelve month low of $171.00 and a twelve month high of $281.70. The stock has a 50-day simple moving average of $200.87 and a two-hundred day simple moving average of $223.98. The company has a current ratio of 1.40, a quick ratio of 1.05 and a debt-to-equity ratio of 0.31. The company has a market capitalization of $139.21 billion, a PE ratio of 36.82, a PEG ratio of 2.66 and a beta of 0.86.

Danaher (NYSE:DHR - Get Free Report) last posted its earnings results on Tuesday, April 22nd. The conglomerate reported $1.88 EPS for the quarter, beating the consensus estimate of $1.62 by $0.26. The firm had revenue of $5.74 billion for the quarter, compared to analyst estimates of $5.58 billion. Danaher had a return on equity of 10.82% and a net margin of 16.33%. On average, equities research analysts anticipate that Danaher Co. will post 7.63 EPS for the current year.

Danaher Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, April 25th. Stockholders of record on Friday, March 28th were given a dividend of $0.32 per share. This represents a $1.28 annualized dividend and a dividend yield of 0.66%. The ex-dividend date of this dividend was Friday, March 28th. This is an increase from Danaher's previous quarterly dividend of $0.27. Danaher's payout ratio is currently 24.85%.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.